DK185283A - Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor - Google Patents
Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor Download PDFInfo
- Publication number
- DK185283A DK185283A DK185283A DK185283A DK185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A
- Authority
- DK
- Denmark
- Prior art keywords
- tricyclic
- intermediates
- relationships
- production
- compounds
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8212139 | 1982-04-27 | ||
| GB8212139 | 1982-04-27 | ||
| GB8230055 | 1982-10-21 | ||
| GB8230055 | 1982-10-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK185283D0 DK185283D0 (da) | 1983-04-26 |
| DK185283A true DK185283A (da) | 1983-10-28 |
Family
ID=26282657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK185283A DK185283A (da) | 1982-04-27 | 1983-04-26 | Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4902701A (show.php) |
| EP (1) | EP0093381B1 (show.php) |
| AU (1) | AU566167B2 (show.php) |
| CA (1) | CA1222516A (show.php) |
| DE (1) | DE3364674D1 (show.php) |
| DK (1) | DK185283A (show.php) |
| FI (1) | FI82832C (show.php) |
| GR (1) | GR78142B (show.php) |
| IE (1) | IE55228B1 (show.php) |
| IL (1) | IL68498A (show.php) |
| NZ (1) | NZ204003A (show.php) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8309260D0 (en) * | 1983-04-06 | 1983-05-11 | Erba Farmitalia | Condensed benzopyrone derivatives |
| GB8328494D0 (en) * | 1983-10-25 | 1983-11-23 | Wellcome Found | Liquid containment systems |
| US4861795A (en) * | 1988-06-23 | 1989-08-29 | Rorer Pharmaceutical Corporation | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
| US4849416A (en) * | 1988-07-25 | 1989-07-18 | Rorer Pharmaceutical Corporation | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
| US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
| IT1261662B (it) * | 1992-09-07 | 1996-05-28 | Inverni Della Beffa Spa | Derivati xantonici, loro preparazione ed attivita' |
| US5624794A (en) * | 1995-06-05 | 1997-04-29 | The Regents Of The University Of California | Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas |
| US5977077A (en) * | 1995-08-28 | 1999-11-02 | Interlab Corporation | Xanthone analogs for the treatment of infectious diseases |
| US6221637B1 (en) | 1996-03-05 | 2001-04-24 | Takeda Chemical Industries, Ltd. | Xanthene derivatives, their production and use |
| US6355153B1 (en) * | 1999-09-17 | 2002-03-12 | Nutool, Inc. | Chip interconnect and packaging deposition methods and structures |
| US7506438B1 (en) * | 2000-11-14 | 2009-03-24 | Freescale Semiconductor, Inc. | Low profile integrated module interconnects and method of fabrication |
| US8828226B2 (en) | 2003-03-01 | 2014-09-09 | The Trustees Of Boston University | System for assessing the efficacy of stored red blood cells using microvascular networks |
| US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
| JP2013507447A (ja) | 2009-10-12 | 2013-03-04 | ニュー ヘルス サイエンシーズ、インク． | 酸素減損装置及び赤血球から酸素を除去する方法 |
| CN102711865B (zh) | 2009-10-12 | 2015-08-19 | 新健康科学股份有限公司 | 具有氧和二氧化碳消耗能力的血液贮藏袋系统和消耗装置 |
| US12089589B2 (en) | 2009-10-12 | 2024-09-17 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
| US9199016B2 (en) | 2009-10-12 | 2015-12-01 | New Health Sciences, Inc. | System for extended storage of red blood cells and methods of use |
| US9339025B2 (en) | 2010-08-25 | 2016-05-17 | New Health Sciences, Inc. | Method for enhancing red blood cell quality and survival during storage |
| WO2012061731A1 (en) | 2010-11-05 | 2012-05-10 | New Health Sciences | Irradiation of red blood cells and anaerobic storage |
| US9067004B2 (en) | 2011-03-28 | 2015-06-30 | New Health Sciences, Inc. | Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly |
| ES2923571T3 (es) | 2011-08-10 | 2022-09-28 | Hemanext Inc | Dispositivo integrado de filtrado de leucocitos, oxígeno y/o CO2 y separación de plasma |
| PT2961269T (pt) | 2013-02-28 | 2021-12-16 | Hemanext Inc | Dispositivo de depleção de gás para produtos sanguíneos |
| ES2902499T3 (es) | 2015-03-10 | 2022-03-28 | Hemanext Inc | Kits desechables de reducción de oxígeno, dispositivos y procedimientos de uso de los mismos |
| KR102845950B1 (ko) | 2015-04-23 | 2025-08-12 | 헤마넥스트 인코포레이티드 | 혐기성 혈액 저장 용기 |
| KR102675532B1 (ko) | 2015-05-18 | 2024-06-13 | 헤마넥스트 인코포레이티드 | 전혈의 저장 방법, 및 그것의 조성물 |
| KR20240132129A (ko) | 2016-05-27 | 2024-09-02 | 헤마넥스트 인코포레이티드 | 혐기성 혈액 저장 및 병원체 불활성화 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2783246A (en) * | 1955-05-02 | 1957-02-26 | Allied Chem & Dye Corp | Manufacture of xanthene |
| BE759292A (fr) * | 1969-11-27 | 1971-05-24 | Allen & Hanburys Ltd | Derives de xanthone, leur preparation et leur emploi |
| US4061768A (en) * | 1971-09-08 | 1977-12-06 | Burroughs Wellcome Co. | Certain cyclic carbonyl compounds used in the prophylaxis of allergic conditions |
| AU478775B2 (en) * | 1974-09-13 | 1974-12-12 | Syntex Gu. S. A. ) Inc | Novel substituted xanthone carboxylic acid compounds |
-
1983
- 1983-04-26 GR GR71216A patent/GR78142B/el unknown
- 1983-04-26 AU AU13924/83A patent/AU566167B2/en not_active Ceased
- 1983-04-26 CA CA000426692A patent/CA1222516A/en not_active Expired
- 1983-04-26 IE IE949/83A patent/IE55228B1/en unknown
- 1983-04-26 FI FI831420A patent/FI82832C/fi not_active IP Right Cessation
- 1983-04-26 NZ NZ204003A patent/NZ204003A/en unknown
- 1983-04-26 DK DK185283A patent/DK185283A/da not_active Application Discontinuation
- 1983-04-26 IL IL68498A patent/IL68498A/xx unknown
- 1983-04-26 EP EP83104086A patent/EP0093381B1/en not_active Expired
- 1983-04-26 DE DE8383104086T patent/DE3364674D1/de not_active Expired
-
1986
- 1986-09-03 US US06/903,834 patent/US4902701A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GR78142B (show.php) | 1984-09-26 |
| FI82832B (fi) | 1991-01-15 |
| DE3364674D1 (en) | 1986-08-28 |
| IE830949L (en) | 1983-10-27 |
| NZ204003A (en) | 1986-05-09 |
| IL68498A0 (en) | 1983-07-31 |
| US4902701A (en) | 1990-02-20 |
| AU1392483A (en) | 1983-11-03 |
| IE55228B1 (en) | 1990-07-04 |
| AU566167B2 (en) | 1987-10-08 |
| EP0093381B1 (en) | 1986-07-23 |
| IL68498A (en) | 1986-09-30 |
| FI831420A0 (fi) | 1983-04-26 |
| CA1222516A (en) | 1987-06-02 |
| FI82832C (fi) | 1991-04-25 |
| EP0093381A1 (en) | 1983-11-09 |
| DK185283D0 (da) | 1983-04-26 |
| FI831420L (fi) | 1983-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK185283A (da) | Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor | |
| Bodo | The effect of the “heart-tonics” and other drugs upon the heart-tone and coronary circulation | |
| BR9608404A (pt) | Processo para armazenar células sanguìneas vermelhas. | |
| Galletti | Laboratory experience with 24 hour partial heart-lung bypass | |
| DE58906387D1 (de) | Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica. | |
| Edoute et al. | Evidence for improved myocardial oxygen delivery and function during hypoxia in the mole rat | |
| Treasure | The safe duration of total circulatory arrest with profound hypothermia | |
| Selman et al. | The effect of hypothermia on survival rates following coronary occlusion in dogs | |
| SU813844A1 (ru) | Состав дл низкотемпературного консервировани лейкоцитов | |
| Lovric | Alterations in blood components during storage and their clinical significance | |
| Rocko et al. | A nonheparinized muscle model for studies of ischemia-reperfusion injury | |
| RU92013578A (ru) | Способ получения стерильных кожных трансплантатов с бактерицидными свойствами | |
| RU2051675C1 (ru) | Способ профилактики некротических осложнений при кожно-пластических операциях | |
| Nakamura et al. | The shape of embryonic cardiac jelly | |
| Wielhorski et al. | The performance of nine human hearts before, during, and after transplantation | |
| Murfitt et al. | Biochemical characteristics of mitochondrial populations and subpopulations isolated from ischemic canine myocardium | |
| Aono et al. | Oxygen transport and delivery in rabbits treated with cyanate | |
| Schwartz et al. | Effect of hypothermia on high-energy phosphate stores and contractile function in supported isolated, blood perfused heart | |
| FA et al. | Myocardial protective effects of warm oxygenated leukocyte-depleted Mood cardioplegia during cardiac valve replacement | |
| Jalonen et al. | Reduced Lactate Washout from the Myocardium after Combining St. Thomas I Type Cardioplegia with Topical Cooling of the Heart: Myocardial Oxygenation and Performance after Cardioplegia in Coronary Artery Bypass Grafting Patients | |
| Lewin | Brain Grafts Benefit Parkinson's Patients: Two Parkinson's disease patients in Mexico City apparently showed dramatic improvement in movement, speech, and other symptoms after receiving transplants from their own adrenals | |
| Hort et al. | The influence of bee venom on the osmotic fragility of human red blood cells | |
| WANG | Hemogram and Clinical Observation before and after FetalLiver Cell Suspension Infusion in the Treatmentof Some Hematological Diseases | |
| Smith et al. | Reduction of ischemia by nitroglycerin and methoxamine: Mechanisms of action | |
| ES2003844A4 (es) | Medio de tratamiento de cabello con un contenido de acido de almandras d,l |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |